[1]Endo K, Takahashi K, Abe T, Hikino H. Structure of forsythoside A, an antibacterial principle of Forsythia suspensa leaves. Heterocycles, 1981, 16: 1311-1314. [2]Platanias L C. Mechanisms of type-I and type-II interferon-mediated signaling. Nature Reviews Immunology, 2005, 5(5): 375-386.[3]Aaronson D S, Horvath C M. A road map for those who don’t know JAK-STAT. Science, 2002, 296(5573): 1653-1655.[4]Paulson M, Press C, Smith E, Tanese N, Levy D E. IFN-stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nature Cell Biology, 2002, 4(2): 140-147.[5]Huang M, Qian F, Hu Y Y, Ang C G, Li Z, Wen Z L. Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-inducible genes. Nature Cell Biology, 2002, 4(10): 774-781.[6]Kaur S, Uddin S, Pltanias L C. The PI3′kinase pathway in interferon signaling. Journal of Interferon and Cytokine Research, 2005, 25(12): 780-787.[7]Lekmine F, Uddin S, Sassano A, Parmar S, Brachmann S M, Majchrzak B, Sonenberg N, Hay N, Fish E N, Plantanias L C. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferon. Journal of Biological Chemistry, 2003, 278(30): 27772-27780.[8]Lekmine F, Sassano A, Uddin S, Smith J, Majchrzak B, Brachmann S M, Hay N, Fish E N, Plantanias L C. Interferon-γ engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Experimental Cell Research, 2004, 295(1): 173-182.[9]Samuel C E. Antiviral actions of interferons. Clinical Microbioogy Reviews, 2001, 14(4): 778-809.[10]Arbouzova N I, Zeidler M P. JAK/STAT signalling in drosophila: insights into conserved regulatory and cellular functions. Development, 2006, 133(14): 2605-2616.[11]O’Shea J J, Gadina M, Schreiber R D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell, 2002, 109: 121-131.[12]Stark G R, Kerr I M, Williams B R, Silverman R H, Schreiber R D. How cells respond to interferons. Biochemistry, 1998, 67: 227-264. [13]Jr Darnell J E, Kerr I M, Stark G R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 1994, 264(5164): 1415-1421.[14]卢年芳, 黄爱龙. 干扰素抗病毒作用的机制. 国外医学•流行病学传染病学分册, 2003, 30(4): 226-228.Lu N F, Huang A L. Interferon antiviral mechanism. Foreign Medical•Epidemiology and Lemology Volumes, 2003, 30(4): 226-228. (in Chinese)[15]毛东有, 张中文, 杨 明, 王惠川, 吴国娟. 连翘酯苷对小鼠的急性毒性及体内诱生IFN2α的研究. 动物医学进展, 2009, 30(6): 15-17.Mao D Y, Zhang Z W, Yang M, Wang H C, Wu G J. The acute toxicity of forsythiaside and the effects on inducing IFN-α in mice. Progress in Veterinary Medicine, 2009, 30(6): 15-17. (in Chinese)[16]马元元, 张中文, 李华伟, 孙健华, 许承扬, 吴国娟. 连翘酯苷对IFN-α和Mx1 表达的影响. 中国农业科学, 2010, 43(15): 3237-3243.Ma Y Y, Zhang Z W, Li H W, Sun J H, Xu C Y, Wu G J. Effects of forsythoside A on the expression of IFN-α and Mx1. Scientia Agricultura Sinica, 2010, 43(15): 3237-3243.[17]Li H W, Wu J F, Zhang Z W, Ma Y Y, Liao F F, Zhang Y, Wu G J. Forsythoside A inhibits the avian infectious bronchitis virus in cell culture. Phytotherapy Research, 2011, 225(3): 338-342.[18]崔建军, 田庚善, 田 地, 曾 争. 干扰素信号传导通路与其基因组多态性网络模型的建立. 遗传, 2008, 30(6): 788-794.Cui J J, Tian G S, Tian D, Zeng Z. An integrated biological model for interferon signaling pathway and its gene polymorphisms. Hereditas, 2008, 30(6): 788-794. (in Chinese)[19]Vilcek J. Novel interferons. Nature Immunology, 2003, 4(1): 8-9.[20]Field A K, Tytell A A, Lampson G P, Hilleman M R. Inducers of interferon and host resistance, V. in vitro studies. Biochemistry, 1968, 61(1): 340-346.[21]胡克杰, 曲福君, 孙考祥, 王跃红. 连翘酯甙体外诱生人外周血白细胞中α干扰素的实验研究. 中国中医药科技, 2004, 11(6): 355-356.Hu K J, Qu F J, Sun K X, Wang Y H. The experimental study of forsythiaside induced interferon α in peripheral blood leukocytes. Chinese Journal of Traditional Medical Science and Technology, 2004, 11(6): 355-356. (in Chinese)[22]Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature, 2005, 434(7): 772-777. [23]Nguyen H, Hiscott J, Pitha P M. The growing family of interferon regulatory factors. Cytokine Growth Factor Reviews, 1997, 8(4): 293-312. [24]Scherbik S V, Stockman B M, Brinton M A. Differential expression of interferon (IFN) regulatory factors and IFN-stimulated genes at early times after west nile virus infection of mouse embryo fibroblasts. Journal of Virology, 2007, 81(21): 12005-12018.[25]Durbin J E, Hackenmiller R, Simon M C, Levy D E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell, 1996, 84: 443-450. [26]Park C, Li S. Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity, 2000, 13: 795-804. [27]Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen I Z, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P, Al-Ghonaium A, Tufenkeji H, Frayha H, Al-Gazlan S, Al-Rayes H, Schreiber R D, Gresser I, Casanova JL. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nature Genetics, 2003, 33: 388-391. |